Intranasal Sufentanyl analgesia Versus Morphine IV in Emergency room.

Intranasal Sufentanyl analgesia Versus Morphine IV in Emergency room. - ALGOFINE 2

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-001665-16-FR

Enrollment

220

Registered

2015-09-22

Start date

2013-08-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Sufentanil Mylan Product Name: SUFENTANIL Pharmaceutical Form: Nasal spray, solution Pharmaceutical form of the placebo: Solution for inject

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 220 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactBlancher

University Hospital Grenoble

MBlancher@chu-grenoble.fr33047676630246

Outcome results